

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle cell fate commitment (GO:0042693) | 6.72045679 |
| 2 | creatine metabolic process (GO:0006600) | 6.40457231 |
| 3 | lysine catabolic process (GO:0006554) | 5.70686424 |
| 4 | lysine metabolic process (GO:0006553) | 5.70686424 |
| 5 | muscle organ morphogenesis (GO:0048644) | 5.70251243 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.69348925 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.69348925 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.53133601 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 5.53133601 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.39817522 |
| 11 | ribosomal small subunit biogenesis (GO:0042274) | 5.34013180 |
| 12 | cellular ketone body metabolic process (GO:0046950) | 5.18936905 |
| 13 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.16897916 |
| 14 | actin-myosin filament sliding (GO:0033275) | 5.16496207 |
| 15 | muscle filament sliding (GO:0030049) | 5.16496207 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.05936200 |
| 17 | cysteine metabolic process (GO:0006534) | 4.99564117 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 4.89033909 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.84906239 |
| 20 | aspartate family amino acid catabolic process (GO:0009068) | 4.81350320 |
| 21 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.75112652 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 4.74637881 |
| 23 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.74577514 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.73952605 |
| 25 | short-chain fatty acid metabolic process (GO:0046459) | 4.72312281 |
| 26 | 2-oxoglutarate metabolic process (GO:0006103) | 4.66409971 |
| 27 | tricarboxylic acid cycle (GO:0006099) | 4.65080335 |
| 28 | ketone body metabolic process (GO:1902224) | 4.61320997 |
| 29 | fatty acid beta-oxidation (GO:0006635) | 4.55850051 |
| 30 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.52571643 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 4.46097441 |
| 32 | tooth mineralization (GO:0034505) | 4.39073019 |
| 33 | indole-containing compound catabolic process (GO:0042436) | 4.37660999 |
| 34 | indolalkylamine catabolic process (GO:0046218) | 4.37660999 |
| 35 | tryptophan catabolic process (GO:0006569) | 4.37660999 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.33928344 |
| 37 | carnitine shuttle (GO:0006853) | 4.33553516 |
| 38 | fatty acid transmembrane transport (GO:1902001) | 4.27937780 |
| 39 | viral transcription (GO:0019083) | 4.21997179 |
| 40 | acetyl-CoA metabolic process (GO:0006084) | 4.21976534 |
| 41 | alpha-linolenic acid metabolic process (GO:0036109) | 4.21926084 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.21325628 |
| 43 | bile acid biosynthetic process (GO:0006699) | 4.20468251 |
| 44 | ethanol oxidation (GO:0006069) | 4.17929656 |
| 45 | fatty acid oxidation (GO:0019395) | 4.17913143 |
| 46 | branched-chain amino acid catabolic process (GO:0009083) | 4.17671093 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.17456379 |
| 48 | lymph vessel development (GO:0001945) | 4.13756410 |
| 49 | fatty acid catabolic process (GO:0009062) | 4.10821876 |
| 50 | lipid oxidation (GO:0034440) | 4.10105052 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.07927478 |
| 52 | skeletal muscle contraction (GO:0003009) | 4.07440259 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 4.07406987 |
| 54 | tryptophan metabolic process (GO:0006568) | 4.07217325 |
| 55 | glycine metabolic process (GO:0006544) | 4.03288704 |
| 56 | cellular modified amino acid catabolic process (GO:0042219) | 4.00582196 |
| 57 | gluconeogenesis (GO:0006094) | 4.00033630 |
| 58 | cardiac muscle contraction (GO:0060048) | 3.99881165 |
| 59 | glutamate metabolic process (GO:0006536) | 3.97331291 |
| 60 | monocarboxylic acid catabolic process (GO:0072329) | 3.95151129 |
| 61 | amyloid precursor protein catabolic process (GO:0042987) | 3.93821746 |
| 62 | serine family amino acid metabolic process (GO:0009069) | 3.92245108 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.90976683 |
| 64 | carnitine metabolic process (GO:0009437) | 3.90018616 |
| 65 | actin-mediated cell contraction (GO:0070252) | 3.86936441 |
| 66 | striated muscle contraction (GO:0006941) | 3.86301991 |
| 67 | urea metabolic process (GO:0019627) | 3.86226528 |
| 68 | urea cycle (GO:0000050) | 3.86226528 |
| 69 | NADH metabolic process (GO:0006734) | 3.85932270 |
| 70 | branched-chain amino acid metabolic process (GO:0009081) | 3.81835906 |
| 71 | sarcomere organization (GO:0045214) | 3.81687407 |
| 72 | translational termination (GO:0006415) | 3.81528779 |
| 73 | organic acid catabolic process (GO:0016054) | 3.80376750 |
| 74 | carboxylic acid catabolic process (GO:0046395) | 3.80376750 |
| 75 | myofibril assembly (GO:0030239) | 3.78984641 |
| 76 | aromatic amino acid family metabolic process (GO:0009072) | 3.76915517 |
| 77 | high-density lipoprotein particle remodeling (GO:0034375) | 3.76527743 |
| 78 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.74675686 |
| 79 | complement activation, alternative pathway (GO:0006957) | 3.74377188 |
| 80 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.71943001 |
| 81 | hexose biosynthetic process (GO:0019319) | 3.68544082 |
| 82 | nitrogen cycle metabolic process (GO:0071941) | 3.68340647 |
| 83 | outer ear morphogenesis (GO:0042473) | 3.68099199 |
| 84 | regulation of protein activation cascade (GO:2000257) | 3.66773315 |
| 85 | oxaloacetate metabolic process (GO:0006107) | 3.66484714 |
| 86 | succinate metabolic process (GO:0006105) | 3.65719383 |
| 87 | negative regulation of fibrinolysis (GO:0051918) | 3.63629771 |
| 88 | valine metabolic process (GO:0006573) | 3.61879614 |
| 89 | tricarboxylic acid metabolic process (GO:0072350) | 3.60792557 |
| 90 | triglyceride homeostasis (GO:0070328) | 3.60682946 |
| 91 | acylglycerol homeostasis (GO:0055090) | 3.60682946 |
| 92 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.60223529 |
| 93 | bile acid metabolic process (GO:0008206) | 3.57979359 |
| 94 | cardiac myofibril assembly (GO:0055003) | 3.57486855 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.55164904 |
| 96 | outflow tract septum morphogenesis (GO:0003148) | 3.54314540 |
| 97 | biotin metabolic process (GO:0006768) | 3.52389040 |
| 98 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.51684636 |
| 99 | translational elongation (GO:0006414) | 3.50686436 |
| 100 | respiratory electron transport chain (GO:0022904) | 3.49856549 |
| 101 | regulation of cardioblast proliferation (GO:0003264) | 3.49647375 |
| 102 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.49647375 |
| 103 | flavonoid metabolic process (GO:0009812) | 3.49644678 |
| 104 | regulation of skeletal muscle contraction (GO:0014819) | 3.49170710 |
| 105 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.49138914 |
| 106 | coenzyme catabolic process (GO:0009109) | 3.48675372 |
| 107 | regulation of complement activation (GO:0030449) | 3.46652138 |
| 108 | monosaccharide biosynthetic process (GO:0046364) | 3.46185053 |
| 109 | tyrosine metabolic process (GO:0006570) | 3.45445258 |
| 110 | amino-acid betaine transport (GO:0015838) | 3.41238096 |
| 111 | carnitine transport (GO:0015879) | 3.41238096 |
| 112 | regulation of cholesterol esterification (GO:0010872) | 3.40893052 |
| 113 | positive regulation of myotube differentiation (GO:0010831) | 3.40702142 |
| 114 | skeletal muscle fiber development (GO:0048741) | 3.40587307 |
| 115 | electron transport chain (GO:0022900) | 3.40494523 |
| 116 | regulation of fatty acid oxidation (GO:0046320) | 3.38141391 |
| 117 | regulation of fibrinolysis (GO:0051917) | 3.36655079 |
| 118 | ATP synthesis coupled proton transport (GO:0015986) | 3.36171353 |
| 119 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.36171353 |
| 120 | dicarboxylic acid metabolic process (GO:0043648) | 3.35627016 |
| 121 | carnitine transmembrane transport (GO:1902603) | 3.35206112 |
| 122 | * oxidative phosphorylation (GO:0006119) | 3.34474109 |
| 123 | thyroid gland development (GO:0030878) | 3.33346583 |
| 124 | fatty acid homeostasis (GO:0055089) | 3.32518491 |
| 125 | regulation of sequestering of triglyceride (GO:0010889) | 3.31804293 |
| 126 | negative regulation of cholesterol transport (GO:0032375) | 3.31595275 |
| 127 | negative regulation of sterol transport (GO:0032372) | 3.31595275 |
| 128 | regulation of cholesterol homeostasis (GO:2000188) | 3.31056691 |
| 129 | cellular glucuronidation (GO:0052695) | 3.29759397 |
| 130 | protein carboxylation (GO:0018214) | 3.28664050 |
| 131 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.28664050 |
| 132 | benzene-containing compound metabolic process (GO:0042537) | 3.28357596 |
| 133 | response to mercury ion (GO:0046689) | 3.27756274 |
| 134 | protein-lipid complex remodeling (GO:0034368) | 3.27679863 |
| 135 | macromolecular complex remodeling (GO:0034367) | 3.27679863 |
| 136 | plasma lipoprotein particle remodeling (GO:0034369) | 3.27679863 |
| 137 | embryonic viscerocranium morphogenesis (GO:0048703) | 3.26592253 |
| 138 | * ATP biosynthetic process (GO:0006754) | 3.21548745 |
| 139 | regulation of relaxation of muscle (GO:1901077) | 3.20235151 |
| 140 | fructose metabolic process (GO:0006000) | 3.19548924 |
| 141 | protein complex biogenesis (GO:0070271) | 3.17092393 |
| 142 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.15227562 |
| 143 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.10834943 |
| 144 | coronary vasculature morphogenesis (GO:0060977) | 3.04903301 |
| 145 | pentose metabolic process (GO:0019321) | 3.00880472 |
| 146 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.99996540 |
| 147 | viral life cycle (GO:0019058) | 2.99607577 |
| 148 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.98710785 |
| 149 | amyloid precursor protein metabolic process (GO:0042982) | 2.98030863 |
| 150 | muscle tissue morphogenesis (GO:0060415) | 2.98010263 |
| 151 | histone arginine methylation (GO:0034969) | 2.97195771 |
| 152 | regulation of oxidative phosphorylation (GO:0002082) | 2.96200919 |
| 153 | * purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.94975738 |
| 154 | protein targeting to ER (GO:0045047) | 2.94783239 |
| 155 | nucleotide salvage (GO:0043173) | 2.90631828 |
| 156 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.90480495 |
| 157 | negative regulation of myotube differentiation (GO:0010832) | 2.88696588 |
| 158 | cotranslational protein targeting to membrane (GO:0006613) | 2.88320563 |
| 159 | * purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.87987128 |
| 160 | regulation of cellular respiration (GO:0043457) | 2.87831324 |
| 161 | response to muscle activity (GO:0014850) | 2.87596414 |
| 162 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.87373116 |
| 163 | NADH dehydrogenase complex assembly (GO:0010257) | 2.87373116 |
| 164 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.87373116 |
| 165 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.86457181 |
| 166 | myotube cell development (GO:0014904) | 2.85611695 |
| 167 | cellular protein complex disassembly (GO:0043624) | 2.84614843 |
| 168 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.84195600 |
| 169 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.82160683 |
| 170 | protein localization to endoplasmic reticulum (GO:0070972) | 2.81327574 |
| 171 | mitochondrial transport (GO:0006839) | 2.81238930 |
| 172 | galactose catabolic process (GO:0019388) | 2.80885104 |
| 173 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.79971395 |
| 174 | regulation of cardioblast differentiation (GO:0051890) | 2.79779166 |
| 175 | heart trabecula formation (GO:0060347) | 2.77635457 |
| 176 | proline biosynthetic process (GO:0006561) | 2.77321495 |
| 177 | * ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.76475412 |
| 178 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.75285987 |
| 179 | ubiquinone biosynthetic process (GO:0006744) | 2.74601646 |
| 180 | maturation of SSU-rRNA (GO:0030490) | 2.73928894 |
| 181 | pharyngeal system development (GO:0060037) | 2.73384260 |
| 182 | cranial nerve morphogenesis (GO:0021602) | 2.71679788 |
| 183 | peptidyl-histidine modification (GO:0018202) | 2.71307694 |
| 184 | regulation of actin filament-based movement (GO:1903115) | 2.70113921 |
| 185 | protein targeting to mitochondrion (GO:0006626) | 2.69981934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.05810464 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.86569191 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.10743511 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.58228976 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.51750906 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.00975149 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.92377095 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.60730443 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.43839797 |
| 10 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.41721313 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.17793290 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.00768835 |
| 13 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.53766434 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.48245899 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43651032 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.37519364 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.36592331 |
| 18 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.15580946 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.07391527 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.00861276 |
| 21 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.00017669 |
| 22 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.93625199 |
| 23 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.89835015 |
| 24 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.85766146 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.79138748 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77332599 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.65286944 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 1.64601185 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.59129305 |
| 30 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.57317848 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53667679 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53610778 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53075569 |
| 34 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.52622042 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52522954 |
| 36 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.52461686 |
| 37 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.50427624 |
| 38 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.50045015 |
| 39 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48566514 |
| 40 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.45669324 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45555248 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.45518741 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43772767 |
| 44 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.42540147 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40447598 |
| 46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.38811085 |
| 47 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.37892972 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.37071811 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36412460 |
| 50 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.36407925 |
| 51 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35278126 |
| 52 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.33418774 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28947422 |
| 54 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.28332151 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26537157 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26372694 |
| 57 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25499962 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24290728 |
| 59 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.23500047 |
| 60 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22971630 |
| 61 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.22769966 |
| 62 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21758424 |
| 63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21531040 |
| 64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20800065 |
| 65 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.18738332 |
| 66 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.16360542 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14814917 |
| 68 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.14472644 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.14132194 |
| 70 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13780229 |
| 71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13750319 |
| 72 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11445891 |
| 73 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.10114379 |
| 74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09454410 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08522908 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07335738 |
| 77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.06682389 |
| 78 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.05977736 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05925650 |
| 80 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05820610 |
| 81 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05770792 |
| 82 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.05457503 |
| 83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.05352862 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.05342412 |
| 85 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04699528 |
| 86 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.04512472 |
| 87 | P68_20966046_ChIP-Seq_HELA_Human | 1.04193733 |
| 88 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.03948808 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03394681 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03365142 |
| 91 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.03026033 |
| 92 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.01489528 |
| 93 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.01489528 |
| 94 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.01489528 |
| 95 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00201416 |
| 96 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00201416 |
| 97 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00084340 |
| 98 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99312315 |
| 99 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98771755 |
| 100 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97131877 |
| 101 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96703200 |
| 102 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96331435 |
| 103 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95207773 |
| 104 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.94321468 |
| 105 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93976215 |
| 106 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.92852517 |
| 107 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.92693801 |
| 108 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.91958634 |
| 109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.91876873 |
| 110 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91815630 |
| 111 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.90535401 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89395445 |
| 113 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.89276450 |
| 114 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.88689745 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88569187 |
| 116 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.88154836 |
| 117 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83989084 |
| 118 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83969634 |
| 119 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82779212 |
| 120 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82022119 |
| 121 | SA1_27219007_Chip-Seq_Bcells_Human | 0.80067167 |
| 122 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.78949038 |
| 123 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.78562894 |
| 124 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78271194 |
| 125 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77863956 |
| 126 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77403319 |
| 127 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.77350974 |
| 128 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.77327826 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76343039 |
| 130 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73406722 |
| 131 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.73129598 |
| 132 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.73056008 |
| 133 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.73007096 |
| 134 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.72657396 |
| 135 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.72326827 |
| 136 | GATA1_22025678_ChIP-Seq_K562_Human | 0.71318006 |
| 137 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.70401674 |
| 138 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.69801935 |
| 139 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.68963200 |
| 140 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.68752126 |
| 141 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.68588564 |
| 142 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.68492838 |
| 143 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.68362204 |
| 144 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.67783995 |
| 145 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.66016362 |
| 146 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.65435561 |
| 147 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.65262567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.02212805 |
| 2 | MP0005360_urolithiasis | 5.70033782 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.97286531 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 4.60104654 |
| 5 | MP0005365_abnormal_bile_salt | 4.49884907 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.67492790 |
| 7 | MP0003646_muscle_fatigue | 3.62482650 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.55338956 |
| 9 | MP0002234_abnormal_pharynx_morphology | 3.35541068 |
| 10 | MP0000678_abnormal_parathyroid_gland | 3.11071333 |
| 11 | MP0003252_abnormal_bile_duct | 2.99355218 |
| 12 | MP0009840_abnormal_foam_cell | 2.84262924 |
| 13 | MP0005332_abnormal_amino_acid | 2.78848748 |
| 14 | MP0002249_abnormal_larynx_morphology | 2.75723698 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.60148257 |
| 16 | MP0005083_abnormal_biliary_tract | 2.52352243 |
| 17 | MP0003195_calcinosis | 2.50085220 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 2.47087379 |
| 19 | MP0004084_abnormal_cardiac_muscle | 2.34276973 |
| 20 | MP0000733_abnormal_muscle_development | 2.16201515 |
| 21 | MP0005330_cardiomyopathy | 2.14795448 |
| 22 | MP0004510_myositis | 2.13543231 |
| 23 | MP0000751_myopathy | 2.08126666 |
| 24 | MP0004036_abnormal_muscle_relaxation | 2.02530608 |
| 25 | MP0010030_abnormal_orbit_morphology | 2.01333564 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.98151762 |
| 27 | MP0004858_abnormal_nervous_system | 1.96197153 |
| 28 | MP0002163_abnormal_gland_morphology | 1.94958101 |
| 29 | MP0004130_abnormal_muscle_cell | 1.94222730 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.91425636 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.87597339 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.83510452 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.80727084 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.77653392 |
| 35 | MP0005670_abnormal_white_adipose | 1.77489523 |
| 36 | MP0002269_muscular_atrophy | 1.70272089 |
| 37 | MP0000749_muscle_degeneration | 1.69251358 |
| 38 | MP0000609_abnormal_liver_physiology | 1.67385856 |
| 39 | MP0003879_abnormal_hair_cell | 1.65868085 |
| 40 | MP0005623_abnormal_meninges_morphology | 1.64191666 |
| 41 | MP0006035_abnormal_mitochondrial_morpho | 1.62961606 |
| 42 | MP0004043_abnormal_pH_regulation | 1.56603320 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56524742 |
| 44 | MP0003186_abnormal_redox_activity | 1.55490090 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.52503954 |
| 46 | MP0004087_abnormal_muscle_fiber | 1.52491069 |
| 47 | MP0005666_abnormal_adipose_tissue | 1.51761884 |
| 48 | MP0005266_abnormal_metabolism | 1.47432308 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.44242847 |
| 50 | MP0001346_abnormal_lacrimal_gland | 1.37244493 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.36962699 |
| 52 | MP0001764_abnormal_homeostasis | 1.35957092 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.35849821 |
| 54 | MP0000049_abnormal_middle_ear | 1.35049381 |
| 55 | MP0003137_abnormal_impulse_conducting | 1.32397229 |
| 56 | MP0000750_abnormal_muscle_regeneration | 1.31607462 |
| 57 | MP0000681_abnormal_thyroid_gland | 1.27246619 |
| 58 | MP0008775_abnormal_heart_ventricle | 1.26554593 |
| 59 | MP0004233_abnormal_muscle_weight | 1.24799068 |
| 60 | MP0005451_abnormal_body_composition | 1.24427506 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.23217925 |
| 62 | MP0000747_muscle_weakness | 1.23078077 |
| 63 | MP0002972_abnormal_cardiac_muscle | 1.22809982 |
| 64 | MP0009379_abnormal_foot_pigmentation | 1.22760215 |
| 65 | MP0001544_abnormal_cardiovascular_syste | 1.22752558 |
| 66 | MP0005385_cardiovascular_system_phenoty | 1.22752558 |
| 67 | MP0010630_abnormal_cardiac_muscle | 1.22017088 |
| 68 | MP0005166_decreased_susceptibility_to | 1.20093944 |
| 69 | MP0000003_abnormal_adipose_tissue | 1.19184803 |
| 70 | MP0005620_abnormal_muscle_contractility | 1.17985604 |
| 71 | MP0002332_abnormal_exercise_endurance | 1.15708883 |
| 72 | MP0002132_abnormal_respiratory_system | 1.14946814 |
| 73 | MP0002822_catalepsy | 1.12917965 |
| 74 | MP0006138_congestive_heart_failure | 1.09167071 |
| 75 | MP0002877_abnormal_melanocyte_morpholog | 1.08919337 |
| 76 | MP0002106_abnormal_muscle_physiology | 1.07376872 |
| 77 | MP0000343_altered_response_to | 1.05955871 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 1.00812629 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99895889 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 0.99101416 |
| 81 | MP0003283_abnormal_digestive_organ | 0.98402715 |
| 82 | MP0003075_altered_response_to | 0.96989089 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 0.96655458 |
| 84 | MP0005376_homeostasis/metabolism_phenot | 0.95905421 |
| 85 | MP0003868_abnormal_feces_composition | 0.95014166 |
| 86 | MP0002971_abnormal_brown_adipose | 0.92617668 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.92585790 |
| 88 | MP0000598_abnormal_liver_morphology | 0.90737667 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 0.89516214 |
| 90 | MP0005535_abnormal_body_temperature | 0.84722793 |
| 91 | MP0000759_abnormal_skeletal_muscle | 0.83008318 |
| 92 | MP0004145_abnormal_muscle_electrophysio | 0.82948319 |
| 93 | MP0004484_altered_response_of | 0.82703210 |
| 94 | MP0001756_abnormal_urination | 0.81337060 |
| 95 | MP0005369_muscle_phenotype | 0.80281458 |
| 96 | MP0008260_abnormal_autophagy | 0.79153073 |
| 97 | MP0005647_abnormal_sex_gland | 0.77765982 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.75846424 |
| 99 | MP0001873_stomach_inflammation | 0.74924113 |
| 100 | MP0004085_abnormal_heartbeat | 0.73889489 |
| 101 | MP0000013_abnormal_adipose_tissue | 0.72194046 |
| 102 | MP0002127_abnormal_cardiovascular_syste | 0.71382980 |
| 103 | MP0008932_abnormal_embryonic_tissue | 0.71004653 |
| 104 | MP0009642_abnormal_blood_homeostasis | 0.70403639 |
| 105 | MP0003011_delayed_dark_adaptation | 0.66686314 |
| 106 | MP0000230_abnormal_systemic_arterial | 0.66404789 |
| 107 | MP0005334_abnormal_fat_pad | 0.64569456 |
| 108 | MP0005165_increased_susceptibility_to | 0.64406203 |
| 109 | MP0009250_abnormal_appendicular_skeleto | 0.63753755 |
| 110 | MP0008872_abnormal_physiological_respon | 0.61544033 |
| 111 | MP0003718_maternal_effect | 0.58137749 |
| 112 | MP0003303_peritoneal_inflammation | 0.57518680 |
| 113 | MP0003123_paternal_imprinting | 0.57397397 |
| 114 | MP0003329_amyloid_beta_deposits | 0.56537638 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.56535776 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.56359850 |
| 117 | MP0001661_extended_life_span | 0.55619771 |
| 118 | MP0009763_increased_sensitivity_to | 0.55417154 |
| 119 | MP0000762_abnormal_tongue_morphology | 0.55370734 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.54356199 |
| 121 | MP0003878_abnormal_ear_physiology | 0.54356199 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.52289503 |
| 123 | MP0000604_amyloidosis | 0.51661458 |
| 124 | MP0002277_abnormal_respiratory_mucosa | 0.51658530 |
| 125 | MP0003567_abnormal_fetal_cardiomyocyte | 0.51644490 |
| 126 | MP0003953_abnormal_hormone_level | 0.51154951 |
| 127 | MP0002108_abnormal_muscle_morphology | 0.50514788 |
| 128 | MP0002970_abnormal_white_adipose | 0.50495915 |
| 129 | MP0004270_analgesia | 0.50491153 |
| 130 | MP0002796_impaired_skin_barrier | 0.50338104 |
| 131 | MP0003693_abnormal_embryo_hatching | 0.49792915 |
| 132 | MP0005501_abnormal_skin_physiology | 0.49672583 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.49192419 |
| 134 | MP0005167_abnormal_blood-brain_barrier | 0.48613365 |
| 135 | MP0001188_hyperpigmentation | 0.46409881 |
| 136 | MP0001270_distended_abdomen | 0.46395507 |
| 137 | MP0005448_abnormal_energy_balance | 0.46254547 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.44678028 |
| 139 | MP0008874_decreased_physiological_sensi | 0.44018757 |
| 140 | MP0008469_abnormal_protein_level | 0.43985444 |
| 141 | MP0001502_abnormal_circadian_rhythm | 0.42889229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 5.49953737 |
| 2 | Congenital malformation of the right heart (HP:0011723) | 5.48118297 |
| 3 | Double outlet right ventricle (HP:0001719) | 5.48118297 |
| 4 | Nemaline bodies (HP:0003798) | 5.22244728 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.17973096 |
| 6 | Hyperglycinuria (HP:0003108) | 4.98767003 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.69736600 |
| 8 | Hyperammonemia (HP:0001987) | 4.60195126 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 4.53511074 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.46810020 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 4.39690292 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.39690292 |
| 13 | Ketosis (HP:0001946) | 4.38979564 |
| 14 | Myopathic facies (HP:0002058) | 4.29402926 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.23140368 |
| 16 | Hyperglycinemia (HP:0002154) | 4.20376459 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 4.13316458 |
| 18 | Myoglobinuria (HP:0002913) | 4.12978635 |
| 19 | Xanthomatosis (HP:0000991) | 4.11349832 |
| 20 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.05201977 |
| 21 | Dicarboxylic aciduria (HP:0003215) | 4.05201977 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.03381972 |
| 23 | Deep venous thrombosis (HP:0002625) | 4.01267412 |
| 24 | Ketoacidosis (HP:0001993) | 4.00626663 |
| 25 | Cerebral edema (HP:0002181) | 3.83318801 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 3.79925809 |
| 27 | Subaortic stenosis (HP:0001682) | 3.79514428 |
| 28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.79514428 |
| 29 | Hypoplastic left heart (HP:0004383) | 3.64773318 |
| 30 | Truncus arteriosus (HP:0001660) | 3.56155254 |
| 31 | Hyperlipoproteinemia (HP:0010980) | 3.51203338 |
| 32 | Exercise-induced myalgia (HP:0003738) | 3.49962489 |
| 33 | Sudden death (HP:0001699) | 3.49371129 |
| 34 | Hepatic necrosis (HP:0002605) | 3.40875474 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.40332348 |
| 36 | Acute encephalopathy (HP:0006846) | 3.39006295 |
| 37 | Lethargy (HP:0001254) | 3.36931837 |
| 38 | Hypolipoproteinemia (HP:0010981) | 3.35708403 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 3.35185713 |
| 40 | Rhabdomyolysis (HP:0003201) | 3.33804913 |
| 41 | Exercise-induced muscle cramps (HP:0003710) | 3.25219060 |
| 42 | Gout (HP:0001997) | 3.23302023 |
| 43 | Distal lower limb muscle weakness (HP:0009053) | 3.23056552 |
| 44 | EMG: myopathic abnormalities (HP:0003458) | 3.22274666 |
| 45 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.17891677 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17332818 |
| 47 | Hyperthyroidism (HP:0000836) | 3.15656995 |
| 48 | Distal arthrogryposis (HP:0005684) | 3.12528971 |
| 49 | Prolonged partial thromboplastin time (HP:0003645) | 3.10465061 |
| 50 | Metabolic acidosis (HP:0001942) | 3.10299381 |
| 51 | Hypoplastic heart (HP:0001961) | 3.07796744 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.03923370 |
| 53 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.99017859 |
| 54 | Exercise intolerance (HP:0003546) | 2.96405849 |
| 55 | Ventricular tachycardia (HP:0004756) | 2.95468431 |
| 56 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.94956115 |
| 57 | Progressive muscle weakness (HP:0003323) | 2.94747431 |
| 58 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.93659387 |
| 59 | Periauricular skin pits (HP:0100277) | 2.91196136 |
| 60 | Preauricular pit (HP:0004467) | 2.91196136 |
| 61 | Increased muscle lipid content (HP:0009058) | 2.89616920 |
| 62 | Palpitations (HP:0001962) | 2.89594201 |
| 63 | Acute necrotizing encephalopathy (HP:0006965) | 2.88874051 |
| 64 | Generalized aminoaciduria (HP:0002909) | 2.86876678 |
| 65 | Abnormality of serum amino acid levels (HP:0003112) | 2.79632137 |
| 66 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.77603773 |
| 67 | Round ear (HP:0100830) | 2.76597826 |
| 68 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.74045844 |
| 69 | Transposition of the great arteries (HP:0001669) | 2.74045844 |
| 70 | Abnormal connection of the cardiac segments (HP:0011545) | 2.74045844 |
| 71 | Delayed CNS myelination (HP:0002188) | 2.73828014 |
| 72 | Hepatocellular necrosis (HP:0001404) | 2.72206709 |
| 73 | Abnormality of methionine metabolism (HP:0010901) | 2.70954261 |
| 74 | Lactic acidosis (HP:0003128) | 2.69140710 |
| 75 | Vomiting (HP:0002013) | 2.69057135 |
| 76 | Complement deficiency (HP:0004431) | 2.68491355 |
| 77 | Abnormality of the aortic arch (HP:0012303) | 2.67874720 |
| 78 | Unilateral renal agenesis (HP:0000122) | 2.65161712 |
| 79 | Calf muscle hypertrophy (HP:0008981) | 2.57291084 |
| 80 | Epidermoid cyst (HP:0200040) | 2.56317434 |
| 81 | Increased variability in muscle fiber diameter (HP:0003557) | 2.55705583 |
| 82 | Proximal tubulopathy (HP:0000114) | 2.54272105 |
| 83 | Abnormality of purine metabolism (HP:0004352) | 2.50456094 |
| 84 | Right ventricular cardiomyopathy (HP:0011663) | 2.50158951 |
| 85 | Increased CSF lactate (HP:0002490) | 2.47863376 |
| 86 | Mitochondrial inheritance (HP:0001427) | 2.47026899 |
| 87 | Abnormality of nucleobase metabolism (HP:0010932) | 2.46508916 |
| 88 | Increased intramyocellular lipid droplets (HP:0012240) | 2.46505126 |
| 89 | Nausea (HP:0002018) | 2.45372304 |
| 90 | Neck muscle weakness (HP:0000467) | 2.44536714 |
| 91 | Abnormality of the calf musculature (HP:0001430) | 2.44349758 |
| 92 | Increased purine levels (HP:0004368) | 2.41123538 |
| 93 | Hyperuricemia (HP:0002149) | 2.41123538 |
| 94 | Hyporeflexia of lower limbs (HP:0002600) | 2.39477309 |
| 95 | Ragged-red muscle fibers (HP:0003200) | 2.39287789 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.39074835 |
| 97 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.38614561 |
| 98 | Rimmed vacuoles (HP:0003805) | 2.37139546 |
| 99 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.35859812 |
| 100 | Increased connective tissue (HP:0009025) | 2.35726393 |
| 101 | Late onset (HP:0003584) | 2.35403157 |
| 102 | Cholelithiasis (HP:0001081) | 2.34845050 |
| 103 | Progressive macrocephaly (HP:0004481) | 2.34456674 |
| 104 | Hyperbilirubinemia (HP:0002904) | 2.33132445 |
| 105 | Bundle branch block (HP:0011710) | 2.32807290 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 2.31705808 |
| 107 | Muscle fiber splitting (HP:0003555) | 2.31305187 |
| 108 | Atrioventricular block (HP:0001678) | 2.30401945 |
| 109 | Heart block (HP:0012722) | 2.28624519 |
| 110 | Neonatal onset (HP:0003623) | 2.28198512 |
| 111 | Areflexia of lower limbs (HP:0002522) | 2.26487192 |
| 112 | Fat malabsorption (HP:0002630) | 2.25710424 |
| 113 | Stridor (HP:0010307) | 2.25346585 |
| 114 | Methylmalonic aciduria (HP:0012120) | 2.22450754 |
| 115 | Abnormality of the tricuspid valve (HP:0001702) | 2.22304644 |
| 116 | Syncope (HP:0001279) | 2.20622272 |
| 117 | Abnormal gallbladder morphology (HP:0012437) | 2.19562905 |
| 118 | Ulnar deviation of the wrist (HP:0003049) | 2.18755255 |
| 119 | Supraventricular tachycardia (HP:0004755) | 2.18533037 |
| 120 | Calcaneovalgus deformity (HP:0001848) | 2.17784428 |
| 121 | Absent phalangeal crease (HP:0006109) | 2.16660748 |
| 122 | Renal Fanconi syndrome (HP:0001994) | 2.16227537 |
| 123 | Hydroxyprolinuria (HP:0003080) | 2.16203302 |
| 124 | Abnormality of proline metabolism (HP:0010907) | 2.16203302 |
| 125 | Glycosuria (HP:0003076) | 2.15332971 |
| 126 | Abnormality of urine glucose concentration (HP:0011016) | 2.15332971 |
| 127 | Joint hemorrhage (HP:0005261) | 2.14918163 |
| 128 | Muscle stiffness (HP:0003552) | 2.13771439 |
| 129 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.12039046 |
| 130 | Lipoatrophy (HP:0100578) | 2.10753333 |
| 131 | Abnormal cartilage morphology (HP:0002763) | 2.10545824 |
| 132 | Respiratory failure (HP:0002878) | 2.10162199 |
| 133 | Supraventricular arrhythmia (HP:0005115) | 2.09838678 |
| 134 | Skin nodule (HP:0200036) | 2.09572172 |
| 135 | Abnormal atrioventricular conduction (HP:0005150) | 2.08245581 |
| 136 | Hypertensive crisis (HP:0100735) | 2.06407739 |
| 137 | Difficulty running (HP:0009046) | 2.03388802 |
| 138 | Dilated cardiomyopathy (HP:0001644) | 2.02559643 |
| 139 | Hypoglycemic seizures (HP:0002173) | 2.02448846 |
| 140 | Hypercholesterolemia (HP:0003124) | 2.01633034 |
| 141 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.00856727 |
| 142 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.00856727 |
| 143 | Abnormality of glycolysis (HP:0004366) | 2.00663192 |
| 144 | Achilles tendon contracture (HP:0001771) | 2.00344176 |
| 145 | Abnormality of the common coagulation pathway (HP:0010990) | 1.99344110 |
| 146 | Ventricular arrhythmia (HP:0004308) | 1.97860293 |
| 147 | Atrial fibrillation (HP:0005110) | 1.97590556 |
| 148 | Microretrognathia (HP:0000308) | 1.96593963 |
| 149 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.93253802 |
| 150 | Skin pits (HP:0100276) | 1.92179831 |
| 151 | Rectal prolapse (HP:0002035) | 1.89884837 |
| 152 | Abnormality of the parathyroid morphology (HP:0011766) | 1.89623172 |
| 153 | Abnormality of the Achilles tendon (HP:0005109) | 1.89139296 |
| 154 | Increased serum lactate (HP:0002151) | 1.89077978 |
| 155 | Increased serum pyruvate (HP:0003542) | 1.86947482 |
| 156 | Esophageal neoplasm (HP:0100751) | 1.86354142 |
| 157 | Neoplasm of head and neck (HP:0012288) | 1.86354142 |
| 158 | Abnormal EKG (HP:0003115) | 1.85546547 |
| 159 | Lipid accumulation in hepatocytes (HP:0006561) | 1.83812808 |
| 160 | EMG: neuropathic changes (HP:0003445) | 1.81799568 |
| 161 | Deformed tarsal bones (HP:0008119) | 1.80587454 |
| 162 | Delusions (HP:0000746) | 1.78448557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.70138395 |
| 2 | SMG1 | 5.26657683 |
| 3 | VRK2 | 4.79885476 |
| 4 | NEK1 | 3.63207925 |
| 5 | PKN2 | 3.13494052 |
| 6 | TAF1 | 3.07132206 |
| 7 | PDK3 | 2.98481037 |
| 8 | PDK4 | 2.98481037 |
| 9 | PRKD3 | 2.79548491 |
| 10 | TTN | 2.78210980 |
| 11 | TRIB3 | 2.70988815 |
| 12 | STK38L | 2.67315498 |
| 13 | ERN1 | 2.61749575 |
| 14 | PHKG2 | 2.60626393 |
| 15 | PHKG1 | 2.60626393 |
| 16 | LMTK2 | 2.50839220 |
| 17 | PINK1 | 2.42203392 |
| 18 | IRAK3 | 2.36515721 |
| 19 | OBSCN | 2.36389002 |
| 20 | MAP3K7 | 1.98092505 |
| 21 | MYLK | 1.90175694 |
| 22 | PIK3CA | 1.85097282 |
| 23 | PRPF4B | 1.82466548 |
| 24 | PDK2 | 1.79702038 |
| 25 | STK16 | 1.76701474 |
| 26 | SIK1 | 1.75627921 |
| 27 | DMPK | 1.72038289 |
| 28 | ARAF | 1.56996712 |
| 29 | TAOK2 | 1.55943193 |
| 30 | MAPKAPK3 | 1.55020289 |
| 31 | FLT3 | 1.46947778 |
| 32 | EEF2K | 1.38391444 |
| 33 | STK38 | 1.35782987 |
| 34 | FGFR4 | 1.31610897 |
| 35 | WNK4 | 1.28904071 |
| 36 | GRK5 | 1.27882908 |
| 37 | MAPKAPK5 | 1.27669095 |
| 38 | MAP3K10 | 1.22366481 |
| 39 | DAPK1 | 1.19928141 |
| 40 | MAPK11 | 1.15574268 |
| 41 | CSNK1G3 | 1.14142142 |
| 42 | KDR | 1.07738740 |
| 43 | MAPK12 | 1.06223102 |
| 44 | VRK1 | 1.06095095 |
| 45 | ICK | 1.04751218 |
| 46 | TIE1 | 1.01221404 |
| 47 | GRK6 | 1.00486799 |
| 48 | MAP2K4 | 1.00159096 |
| 49 | MAP3K11 | 0.99723763 |
| 50 | TAOK3 | 0.98906274 |
| 51 | EPHA2 | 0.97914571 |
| 52 | MAP3K1 | 0.97881442 |
| 53 | CSNK1A1L | 0.94951195 |
| 54 | PIM2 | 0.91469378 |
| 55 | PRKAA1 | 0.90859390 |
| 56 | RIPK1 | 0.90334477 |
| 57 | MAP2K2 | 0.88094633 |
| 58 | MST1R | 0.83636881 |
| 59 | PRKAA2 | 0.82233797 |
| 60 | PDPK1 | 0.78185962 |
| 61 | IRAK2 | 0.77997922 |
| 62 | MAP2K3 | 0.76679090 |
| 63 | DAPK3 | 0.76603817 |
| 64 | CDK4 | 0.75257646 |
| 65 | AKT2 | 0.74165833 |
| 66 | NME2 | 0.73683425 |
| 67 | TAOK1 | 0.73052380 |
| 68 | LIMK1 | 0.72886695 |
| 69 | KSR2 | 0.72354873 |
| 70 | TESK1 | 0.71542417 |
| 71 | ILK | 0.71028630 |
| 72 | BUB1 | 0.70974658 |
| 73 | AURKA | 0.70884951 |
| 74 | INSRR | 0.69977556 |
| 75 | TTK | 0.69927135 |
| 76 | HIPK2 | 0.68048264 |
| 77 | CSNK1G1 | 0.65878680 |
| 78 | PDK1 | 0.65728267 |
| 79 | TBK1 | 0.65054749 |
| 80 | CSNK1G2 | 0.64868245 |
| 81 | PRKACG | 0.62553994 |
| 82 | ERBB4 | 0.62462467 |
| 83 | CAMK2G | 0.62003496 |
| 84 | NME1 | 0.60232617 |
| 85 | ABL2 | 0.59670019 |
| 86 | RPS6KB2 | 0.59134194 |
| 87 | MAP2K1 | 0.59098610 |
| 88 | DAPK2 | 0.58371988 |
| 89 | CDK9 | 0.58227165 |
| 90 | STK11 | 0.56967713 |
| 91 | WNK3 | 0.56681060 |
| 92 | STK4 | 0.56595270 |
| 93 | MAP2K6 | 0.55905744 |
| 94 | CAMK2D | 0.55209243 |
| 95 | PRKD1 | 0.53081919 |
| 96 | RPS6KC1 | 0.52878649 |
| 97 | RPS6KL1 | 0.52878649 |
| 98 | PAK3 | 0.52548551 |
| 99 | TLK1 | 0.51033546 |
| 100 | ZAK | 0.50250593 |
| 101 | MUSK | 0.48807951 |
| 102 | CDC42BPA | 0.48083493 |
| 103 | RAF1 | 0.48070839 |
| 104 | MAP3K5 | 0.46993790 |
| 105 | CAMK4 | 0.46753351 |
| 106 | IKBKB | 0.46732655 |
| 107 | RIPK4 | 0.46488341 |
| 108 | TYK2 | 0.46132431 |
| 109 | BRSK1 | 0.45985772 |
| 110 | CHEK2 | 0.45501718 |
| 111 | EPHA4 | 0.45472168 |
| 112 | AKT3 | 0.45182742 |
| 113 | CAMK2B | 0.45123650 |
| 114 | MELK | 0.43734205 |
| 115 | MAPK4 | 0.43669804 |
| 116 | CCNB1 | 0.43171033 |
| 117 | CAMK1 | 0.42962916 |
| 118 | PTK6 | 0.42598918 |
| 119 | MTOR | 0.42280955 |
| 120 | PIK3CG | 0.41658897 |
| 121 | LRRK2 | 0.40270633 |
| 122 | DYRK3 | 0.39032295 |
| 123 | PRKACB | 0.38637031 |
| 124 | RPS6KA6 | 0.37912460 |
| 125 | PRKACA | 0.37601506 |
| 126 | CDK7 | 0.36100178 |
| 127 | IRAK4 | 0.36029078 |
| 128 | MAP3K3 | 0.36015260 |
| 129 | CAMK1D | 0.35903580 |
| 130 | CDK11A | 0.35692780 |
| 131 | NUAK1 | 0.32801160 |
| 132 | WEE1 | 0.32323435 |
| 133 | LATS2 | 0.32195579 |
| 134 | MAP3K8 | 0.31410655 |
| 135 | CDK15 | 0.31133227 |
| 136 | PRKG2 | 0.29802200 |
| 137 | PAK1 | 0.29490369 |
| 138 | GRK7 | 0.29028147 |
| 139 | RPS6KA5 | 0.28931277 |
| 140 | PRKCZ | 0.28848274 |
| 141 | JAK2 | 0.28767389 |
| 142 | ROCK1 | 0.28727075 |
| 143 | MAPK7 | 0.24902922 |
| 144 | DYRK1B | 0.24407371 |
| 145 | STK24 | 0.23833854 |
| 146 | MET | 0.21982046 |
| 147 | RPS6KA1 | 0.21497007 |
| 148 | BRAF | 0.20018988 |
| 149 | SGK3 | 0.19925010 |
| 150 | MAP3K9 | 0.19860255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.75528306 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.60920400 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.18353804 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.06213744 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.05131508 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.04091782 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.01377061 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.95659978 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.90978044 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.88607280 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.61527455 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.54570416 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.47206071 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.27913376 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.25932070 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.20726925 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.20694702 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.08720722 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.93248740 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90174940 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.83937083 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81422739 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80635382 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.75305276 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.67165684 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63317495 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61173673 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.57692394 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44838065 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.41583073 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.41446715 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40698747 |
| 33 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36164396 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34094055 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.33094723 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31652955 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.30409656 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.29445574 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28106597 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27945481 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.27939792 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27687393 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27102089 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27065948 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26191056 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21175581 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19833622 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.19007982 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.17010255 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13612867 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12452536 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12003335 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09803407 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07290573 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 1.05093724 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95992201 |
| 57 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91659045 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89433828 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89244948 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87791676 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85940563 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82913243 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76214699 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72802372 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.72174837 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71538608 |
| 67 | Bladder cancer_Homo sapiens_hsa05219 | 0.71378404 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65851733 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65554957 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65377340 |
| 71 | DNA replication_Homo sapiens_hsa03030 | 0.63947143 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.62783466 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62021770 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60870471 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60452580 |
| 76 | Base excision repair_Homo sapiens_hsa03410 | 0.56945497 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53983421 |
| 78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52796889 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51692818 |
| 80 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.47248501 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44255620 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43878542 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42500821 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41721873 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39455841 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.38735158 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.37343468 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35020528 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32780493 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30165037 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26834651 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26061376 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25719111 |
| 94 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.24562286 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24355821 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.23897702 |
| 97 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.22246066 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22125994 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21406480 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19645383 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19285811 |
| 102 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.18878026 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17255449 |
| 104 | Proteasome_Homo sapiens_hsa03050 | 0.14574357 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.13218618 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13173257 |
| 107 | RNA polymerase_Homo sapiens_hsa03020 | 0.12490060 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12405476 |
| 109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.10480167 |
| 110 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.08480245 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.07194114 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.05427396 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.05365365 |
| 114 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.05183208 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.03912903 |
| 116 | Viral myocarditis_Homo sapiens_hsa05416 | 0.03513494 |
| 117 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.02375741 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1360485 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.1302589 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1279914 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1082574 |
| 122 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0858646 |
| 123 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.0641112 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0252570 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0195178 |
| 126 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0039454 |

